CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-27 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −5,015 | $50.01 | $251K | 1,126 |
| 2023-12-27 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,400 | 82,600 | ||
| 2023-12-06 | Smith Hunter C Chief Financial Officer | Option exercise | +20,000 | $6.88 | $138K | 81,406 |
| 2023-12-06 | Smith Hunter C Chief Financial Officer | Sale | −20,000 | $40.00 | $800K | 61,406 |
| 2023-12-06 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −20,000 | 111,094 | ||
| 2023-12-05 | Smith Hunter C Chief Financial Officer | Option exercise | +7,026 | $6.88 | $48K | 68,432 |
| 2023-12-05 | Smith Hunter C Chief Financial Officer | Sale | −7,026 | $35.06 | $246K | 61,406 |
| 2023-12-05 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −7,026 | 131,094 | ||
| 2023-11-24 | Smith Hunter C Chief Financial Officer | Option exercise | +10,974 | $6.88 | $76K | 72,380 |
| 2023-11-24 | Smith Hunter C Chief Financial Officer | Sale | −10,974 | $35.02 | $384K | 61,406 |
| 2023-11-24 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,974 | 138,120 | ||
| 2023-11-14 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +27,890 | $6.80 | $190K | 31,631 |
| 2023-11-14 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −27,890 | $32.07 | $894K | 3,741 |
| 2023-11-14 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,890 | 35,860 | ||
| 2023-11-14 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +12,030 | $6.80 | $82K | 13,677 |
| 2023-11-14 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −13,677 | $32.01 | $438K | 0 |
| 2023-11-14 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,030 | 46,412 | ||
| 2023-11-14 | Smith Hunter C Chief Financial Officer | Option exercise | +12,000 | $6.88 | $83K | 73,406 |
| 2023-11-14 | Smith Hunter C Chief Financial Officer | Sale | −12,000 | $30.38 | $365K | 61,406 |
| 2023-11-14 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −12,000 | 149,094 |
Page 32 of 36 · 701 trades